Abiopharma

🔍 DEL MATTO ANDREW H (Executive)

Company: Netskope Inc (NTSK)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: H | shares_owned_after: 42,854.00 | Footnotes: F1
• Sold 150,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 200,000.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 15,625 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 187,500.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4
• Acquired 165,625 shares of Class B Common Stock (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 394,029.00 | transaction_form_type: 4 | Footnotes: F2, F2, F5
• Sold 83,128 shares of Class B Common Stock (Derivative)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 310,901.00 | transaction_form_type: 4 | Footnotes: F2, F6, F2, F5

Footnotes:

• F1: Includes 1,361 shares of Class A Common Stock acquired under the Issuer's employee stock purchase plan on February 27, 2026.
• F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder.
• F3: The remaining restricted stock units, or RSUs, vest on April 1, 2027.
• F4: The remaining RSUs vest in 12 equal quarterly installments beginning on June 1, 2026.
• F5: The shares of Class B Common Stock automatically convert to shares of Class A Common Stock on a 1:1 basis on or prior to September 19, 2035 as set forth in the Issuer's amended and restated certificate of incorporation.
• F6: The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.